Skip to main content

Beneficial ownership — 13D / 13G

87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
SIT INVESTMENT ASSOCIATES INC SRV NXG Cushing Midstream Energy Fund 13G/A 0.81% 2y
Saba Capital Management, L.P. NPCT Nuveen Core Plus Impact Fund 13D/A 11.35% 2y
ORBIMED ADVISORS LLC ELVN Enliven Therapeutics, Inc. 13D/A 19.2% 2y
Apollo Management Holdings GP, LLC SNX Td Synnex Corp 13D/A 6.1% 2y
Bleichroeder LP INVE INVE Technologies, Inc. 13D/A 19.9% 2y
Saba Capital Management, L.P. NOM NUVEEN MISSOURI QUALITY MUNICIPAL INCOME FUND 13D 5.35% 2y
Cano Health, Inc. MSPR MSP Recovery, Inc. 13D/A 0% 2y
David Shan MAMO Massimo Group 13G 77.7% 2y
Gary Bowman BWMN Bowman Consulting Group Ltd. 13D/A 14.43% 2y
Farhad Fred Ebrahimi SSYS Stratasys Ltd. 13D/A 4.9% 2y
Standard General L.P. MDIA Mediaco Holding Inc. 13D/A 95.2% 2y
BAILLIE GIFFORD & CO NIO NIO Inc. 13G/A 0.98% 2y
BAILLIE GIFFORD & CO MBLY Mobileye Global Inc. 13G/A 16.87% 2y
WESTFIELD CAPITAL MANAGEMENT CO LP MURA Mural Oncology plc Ordinary Shares 13G/A 9.15% 2y
CVI Investments, Inc. RNLXY Renalytix plc 13G 6.9% 2y
ARC Global Investments II LLC DJT Trump Media & Technology Group Corp. 13G 9.8% 2y
Anders Hove QTTB Q32 Bio Inc. 13D 6.7% 2y
RA CAPITAL MANAGEMENT, L.P. DYN Dyne Therapeutics, Inc. 13G 6.4% 2y
Encompass Capital Advisors LLC GFR Greenfire Resources Ltd. 13G 5.24% 2y
Deerfield Management Company, L.P. VTYX Ventyx Biosciences, Inc. Common Stock 13G 5.03% 2y
Greater Miami Jewish Federation, Inc. RDVT Red Violet, Inc. 13G/A 0% 2y
SIT INVESTMENT ASSOCIATES INC PPT Franklin Premier Income Trust 13D/A 21.23% 2y
Ariel Emanuel EDR Endeavor Group Holdings, Inc. 13D/A 11.9% 2y
HL Voting Trust HLI Houlihan Lokey, Inc. 13D/A 25.1% 2y
Kimmeridge Energy Management Company, LLC CIVI Civitas Resources, Inc. 13D/A 4.1% 2y
Libman Family Holdings, LLC FOA Finance of America Companies Inc. 13D/A 48.6% 2y
Independence Energy Aggregator L.P. CRGY Crescent Energy Co 13D/A 21.1% 2y
Magnetar Financial LLC DSKE Daseke, Inc. Common Stock 13D/A 0% 2y
Jermyn Street Associates LLC NOTVQ Inotiv, Inc. 13D/A 4.89% 2y
Blackstone Holdings II L.P. FOA Finance of America Companies Inc. 13D/A 55.4% 2y
BPP HoldCo LLC CPE Callon Petroleum Company 13D/A 0% 2y
Bellevue Capital Partners, LLC NYC American Strategic Investment Co. 13D/A 50% 2y
Insight Venture Partners X, L.P. NCNO nCino, Inc. 13D/A 29.8% 2y
Andrew Africk CVV Cvd Equipment Corp 13G/A 18.97% 2y
Altamont Pharmaceutical Holdings, LLC GRTXD Galera Therapeutics, Inc. 13G/A 0% 2y
PERCEPTIVE ADVISORS LLC RYTM Rhythm Pharmaceuticals, Inc. 13D/A 5.4% 2y
REH Company DINO HF Sinclair Corp 13D/A 9% 2y
Waha LATAM Investments Limited DESP Despegar.com, Corp. 13D/A 0% 2y
Madison Square Garden Entertainment Corp. TSQ Townsquare Media, Inc. 13D/A 1.2% 2y
WILLIS CHARLES F IV WLFC Willis Lease Finance Corp 13D/A 44.18% 2y
Stachowiak Raymond C AMS American Shared Hospital Services 13D/A 21.9% 2y
Ninety One UK Ltd VSTA Vasta Platform Limited Class A Ordinary Shares 13G 5.8% 2y
Vellar Opportunities Fund Master, Ltd. OIO OIO Group 13G/A 0% 2y
Gregory George MESO Mesoblast Ltd 13G/A 12.59% 2y
IndexIQ Advisors LLC UUP Invesco DB US Dollar Index Bullish Fund 13G 5.56% 2y
JREP I Logistics Acquisition, LP LPA Logistic Properties of the Americas 13D 83% 2y
HC PropTech Partners III LLC LPA Logistic Properties of the Americas 13G 6.7% 2y
MILLENNIUM MANAGEMENT LLC NARI Inari Medical, Inc. Common Stock 13G 3.8% 2y
ATW Growth Opportunities SPV, LLC KITT Nauticus Robotics, Inc. 13G 9.9% 2y
Lara Sullivan PYXS Pyxis Oncology, Inc. 13D/A 8.89% 2y